99-18925. Agency Information Collection Activities; Submission for OMB Review; Comment Request; Food Canning Establishment Registration, Process Filing and Recordkeeping for Acidified Foods and Thermally Processed Low-Acid Foods in Hermetically ...  

  • [Federal Register Volume 64, Number 142 (Monday, July 26, 1999)]
    [Notices]
    [Pages 40377-40379]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-18925]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 99N-0780]
    
    
    Agency Information Collection Activities; Submission for OMB 
    Review; Comment Request; Food Canning Establishment Registration, 
    Process Filing and Recordkeeping for Acidified Foods and Thermally 
    Processed Low-Acid Foods in Hermetically Sealed Containers
    
    AGENCY: Food and Drug Administration, HHS.
    
    
    [[Page 40378]]
    
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing that the 
    proposed collection of information listed below has been submitted to 
    the Office of Management and Budget (OMB) for review and clearance 
    under the Paperwork Reduction Act of 1995 (the PRA).
    
    DATES: Submit written comments on the collection of information by 
    August 25, 1999.
    
    ADDRESSES: Submit written comments on the collection of information to 
    the Office of Information and Regulatory Affairs, OMB, New Executive 
    Office Bldg., 725 17th St. NW., rm. 10235, Washington, DC 20503, Attn: 
    Wendy Taylor, Desk Officer for FDA.
    
    FOR FURTHER INFORMATION CONTACT: Peggy Schlosburg, Office of 
    Information Resources Management (HFA-250), Food and Drug 
    Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1223.
    
    SUPPLEMENTARY INFORMATION: In compliance with section 3507 of the PRA 
    (44 U.S.C. 3507), FDA has submitted the following proposed collection 
    of information to OMB for review and clearance.
    
    Food Canning Establishment Registration, Process Filing and 
    Recordkeeping for Acidified Foods and Thermally Processed Low-Acid 
    Foods in Hermetically Sealed Containers (21 CFR 108.25(c)(1) and 
    (c)(2), (d), (e), (g); 108.35(c)(1), (c)(2), (d), (e), (f), (h); 
    113.60(c); 113.83; 113.87; 113.89; 113.100; 114.80(b); 114.89; 
    114.100(a) through (d)) (OMB Control Number 0910-0037--Extension)
    
        Under section 402 of the Federal Food, Drug, and Cosmetic Act (the 
    act) (21 U.S.C. 342), FDA is authorized to prevent the interstate 
    distribution of food products that may be injurious to health or that 
    are otherwise adulterated. Under the authority granted to FDA by 
    section 404 of the act (21 U.S.C. 344), FDA's regulations require 
    registration of food processing establishments, filing of process or 
    other data, and maintenance of processing and production records for 
    acidified foods and thermally processed low-acid foods in hermetically 
    sealed containers. These requirements are intended to ensure safe 
    manufacturing, processing, and packing procedures and to permit FDA to 
    verify that these procedures are being followed. Improperly processed 
    low-acid foods present life-threatening hazards if contaminated with 
    foodborne microorganisms, especially Clostridium botulinum. The spores 
    of C. botulinum must be destroyed or inhibited to avoid production of 
    the deadly toxin that causes botulism. This is accomplished with good 
    manufacturing procedures, which must include the use of adequate heat 
    processes or other means of preservation.
        To protect the public health, FDA's regulations require that each 
    firm that manufactures, processes or packs acidified foods or thermally 
    processed low-acid foods in hermetically sealed containers for 
    introduction into interstate commerce register the establishment with 
    the agency using Form FDA 2541 (Secs. 108.25(c)(1) and 108.35(c)(2)) 
    (21 CFR 108.25(c)(1) and 108.35(c)(2))). In addition to registering the 
    plant, each firm is required to provide data on the processes used to 
    produce these foods, using Form FDA 2541a for all methods except 
    aseptic processing, or Form FDA 2541c for aseptic processing of low-
    acid foods in hermetically sealed containers Secs. 108.25(c)(2) and 
    108.35(c)(2)). Plant registration and process filing may be 
    accomplished simultaneously. Process data must be filed prior to 
    packing any new product and operating processes and procedures must be 
    posted near the processing equipment or made available to the operator 
    (21 CFR 113.87(a)).
        Regulations in parts 108, 113, and 114 (21 CFR parts 108, 113, and 
    114) require firms to maintain records showing adherence to the 
    substantive requirements of the regulations. These records must be made 
    available to FDA on request. Firms are also required to document 
    corrective actions when process controls and procedures do not fall 
    within specified limits (Secs. 113.89, 114.89, and 114.100(c)); to 
    report any instance of potential health-endangering spoilage, process 
    deviation, or contamination with microorganisms where any lot of the 
    food has entered distribution in commerce (Secs. 108.25(d) and 
    108.35(d) and (e)); and to develop and keep on file plans for recalling 
    products that may endanger the public health (Secs. 108.25(e) and 
    108.35(f)). To permit lots to be traced after distribution, acidified 
    foods and thermally processed low-acid foods in hermetically sealed 
    containers must be marked with an identifying code (Secs. 113.60(c) 
    (thermally processed foods) and 114.80(b) (acidified foods)).
        In the Federal Register of April 30, 1999 (64 FR 23334), the agency 
    requested comments on the proposed collections of information. No 
    comments were received.
        FDA estimates the burden of this collection of information as 
    follows:
    
                                     Table 1.--Estimated Annual Reporting Burden\1\
    ----------------------------------------------------------------------------------------------------------------
                                                          Annual
        Form No.      21 CFR Section      No. of       Frequency per   Total Annual      Hours per      Total Hours
                                        Respondents      Response        Responses       Response
    ----------------------------------------------------------------------------------------------------------------
    Form FDA 2541    108.25(c)(1)         300               1             300                .17           51
     (Registration)   and
                      108.35(c)(1)
    Form FDA 2541a   108.25(c)(2)       1,000               6.5         6,500                .333       2,165
     (Process         and
     Filing)          108.35(c)(2)
    Form FDA         108.35(c)(2)       1,000                .50          500                .75          375
     2541(c)
     (Process
     Filing)
    Total                                                                                               2,591
    ----------------------------------------------------------------------------------------------------------------
    \1\ There are no capital costs or operating and maintenance costs associated with this collection of
      information.
    
    
                                   Table 2.--Estimated Annual Recordkeeping Burden\1\
    ----------------------------------------------------------------------------------------------------------------
                                                       Annual
            21 CFR Section             No. of       Frequency per   Total Annual      Hours per       Total Hours
                                    Recordkeepers   Recordkeeping      Records      Recordkeeper
    ----------------------------------------------------------------------------------------------------------------
    108, 113, and 114                5,865               1           5,865             250          1,466,250
    ----------------------------------------------------------------------------------------------------------------
    \1\ There are no capital costs or operating and maintenance costs associated with this collection of
      information.
    
    
    [[Page 40379]]
    
        The reporting burden for Secs. 108.25(d) and 108.35(d) and (e) is 
    insignificant because notification of spoilage, process deviation, or 
    contamination of product in distribution occurs less than once a year. 
    Most firms discover these problems before the product is distributed 
    and, therefore, are not required to report the occurrence. To avoid 
    double counting, estimates for Secs. 108.25(g) and 108.35(h) have not 
    been included because they merely cross-reference recordkeeping 
    requirements contained in parts 113 and 114.
    
        Dated: July 19, 1999
    William K. Hubbard,
    Senior Associate Commissioner for Policy, Planning and Legislation.
    [FR Doc. 99-18925 Filed 7-23-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
07/26/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-18925
Dates:
Submit written comments on the collection of information by August 25, 1999.
Pages:
40377-40379 (3 pages)
Docket Numbers:
Docket No. 99N-0780
PDF File:
99-18925.pdf